New York, NY, United States of America

Peihong Dai

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 6.7

ph-index = 4

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Certainly! Here is an article about inventor Peihong Dai:

Title: Innovator Spotlight - Peihong Dai: Pioneering Cancer Immunotherapy

Introduction:

Peihong Dai is a prolific inventor based in New York, NY, with a remarkable portfolio of 11 patents in the fields of oncology, virology, and immunotherapy. His groundbreaking work at the Memorial Sloan Kettering Cancer Center has revolutionized cancer treatment methodologies, particularly in the realm of immunotherapy.

Latest Patents:

1. Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors: This patent focuses on utilizing modified vaccinia virus Ankara (MVA) and recombinant MVA variants to express human FLT3L for cancer immunotherapy, including in combination with immune checkpoint blockade therapy.

2. Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy: This patent explores the use of replication competent attenuated vaccinia virus variants as oncolytic and immunotherapy agents, potentially in combination with immune checkpoint blocking agents.

Career Highlights:

Peihong Dai's career highlights include spearheading innovative research at the Memorial Sloan Kettering Cancer Center, where his work has significantly advanced the field of cancer immunotherapy. His patents reflect a deep commitment to developing novel therapeutic approaches for combating solid tumors.

Collaborations:

Throughout his career, Peihong Dai has collaborated closely with esteemed colleagues such as Liang Deng and Stewart Shuman. Their collective expertise and collaborative efforts have played a crucial role in the successful development of cutting-edge cancer treatments.

Conclusion:

In conclusion, Peihong Dai stands out as a visionary inventor at the forefront of cancer immunotherapy research. His contributions to the field have paved the way for transformative advancements in the treatment of solid tumors, offering hope to patients worldwide. Peihong Dai's relentless pursuit of innovation underscores his enduring impact on the landscape of modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…